CardioComm Solutions Completes Technology Pilot in the Long-Term Patient Care Market with the HeartCheck(tm) ECG Monitor and ...
07 Febrero 2014 - 8:00AM
Access Wire
Arrhythmia Surveillance
Utilized HeartCheck(TM) Device and SMART Monitoring ECG Service
Technologies
TORONTO, ONTARIO - CardioComm Solutions,
Inc. (TSX VENTURE:EKG) ("CardioComm
Solutions" or the "Company") today announced that it is working
within a pilot that uses HeartCheck(TM) ECG testing technology to
support arrhythmia screening and surveillance with long-term care
facilities. The pilot was coordinated by Toronto-based
IN INITIATIVE INC. and
conducted with Responsive Management Inc.
("RMI"), an organization that owns and operates nine long-term care
homes and three retirement residences in Ontario. The program will
utilize the HeartCheck(TM) ECG monitor and SMART
Monitoring ECG service technologies enabled through
GEMSTM Home and focuses
on the early detection of atrial fibrillation ("AF"). The
arrhythmia surveillance program system was implemented as part of a
larger project funded by an education grant
provided by Boehringer Ingleheim (Canada)
Inc.
Residents of
long-term care facilities are at a higher risk for developing
arrhythmias due to their age or co-morbid conditions, or
both. Central to a program of arrhythmia
surveillance is the ability to easily and accurately capture an ECG
at the time a resident is exhibiting symptoms. The resident's provider performs the ECG recording using the
HeartCheck(TM) ECG monitor and then uploads the recording to the
CardioComm Solutions SMART Monitoring ECG service via
GEMSTM Home from a
workstation at a designated nursing station. Through the
cloud-based SMART Monitoring service, ECGs are interpreted by
Canadian physicians who are specifically assigned to the RMI ECG
records. Once interpreted, ECG reports are then automatically
returned to the long-term care facility, using HIPPA compliant data
encryption technologies, where the reports are reviewed by the
physician in charge through GEMSTM
Home.
The goal of the
arrhythmia surveillance program is to assist
long-term care facilities with the early detection of life
threatening arrhythmias, especially AF, and improve the care of the
residents. "AF related
strokes in the elderly are more disabling and more likely to be
fatal. At RMI, we are focused on introducing best practice
initiatives that improve the well-being of our residents through a
resident-centric approach in everything we do," said Derrick Hoare,
Vice President Operations, Responsive Management Inc. "We did not
realize how much of a problem AF is in our homes but now have a
framework to detect and address the issue. Using a
multi-disciplinary team of professionals and the CardioComm
Solutions technologies, a care protocol has been implemented that
addresses early AF detection and initiation of optimal
therapy."
"We are excited to be
part of this initiative designed to develop a standardized approach
to prevent strokes in our residents. The pilot project addresses an
unmet need and we expect that initial results will be presented
soon," said Susan Veenstra, Director of Nursing and Wellness at
Responsive Management Inc.
"RMI has shown leadership in the adoption of a new technology
within the daily medical management of their residents. The RMI ECG
surveillance program incorporates best
practice guidelines to support ongoing ECG testing for all
residents and the training of staff to recognize and respond
appropriately to signs of AF with the goal of preventing the
occurrence of strokes through early AF detection. The program will
reduce unnecessary and costly transfers to the ER which are
stressful to the resident and may result in the arrhythmia not
being found given the episodic nature of AF," said Etienne Grima,
CEO of CardioComm Solutions. "We have been piloting the
HeartCheckTM devices
since August 2013 and are now fully implemented in three of the RMI
locations. A major advance was the GEMSTM Home 1.2 release that allows the
HeartCheck(TM) ECG handheld monitor to interface with the SMART
Monitoring ECG service. We look forward to the successful roll out
of the solution in all of the RMI Ontario locations over the next
few months and to contributing to their mission of maintaining the
best level of care possible for their residents."
"There are more than
630 long-term care facilities in Ontario
alone, according to the Ministry of Health
and Long-Term Care (MOHLTC)," noted Simi
Grosman, a member of the Company's Board of Directors. "Replicating
these numbers across the country speaks to a significant and
rapidly expanding market for CardioComm Solutions'
HeartCheck(TM) ECG monitor and SMART Monitoring ECG
service technologies. The potential impact
that we can make on the early detection of arrhythmias and AF
cannot be overstated."
More information
regarding the HeartCheckTM
products and SMART Monitoring solutions is available
at the Company's web site www.theheartcheck.com.
About CardioComm Solutions
CardioComm Solutions'
patented and proprietary technology is used in products for
recording, viewing, analyzing and storing electrocardiograms (ECGs)
for diagnosis and management of cardiac patients. Products are sold
worldwide through a combination of an external distribution network
and a North American-based sales team. The Company has earned the
ISO 13485 certification, is HPB approved, HIPAA compliant, and has
received FDA market clearance for its software devices. CardioComm
Solutions is headquartered in Toronto, Ontario, Canada, with
offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Forward-looking statements
This release may
contain certain forward-looking statements and forward looking
information with respect to the financial condition, results of
operations and business of CardioComm Solutions and certain of the
plans and objectives of CardioComm Solutions with respect to these
items. Such statements and information
reflect management's current beliefs and are based on information
currently available to management. By their
nature, forward-looking statements and forward-looking information
involve risk and uncertainty because they relate to events and
depend on circumstances that will occur in the future and there are
many factors that could cause actual results and developments to
differ materially from those expressed or implied by these
forward-looking statements and forward-looking
information.
In evaluating these
statements, readers should: specifically consider risks discussed
under the heading "Risk
Factors" in the Company's Annual Information
Form, available at www.sedar.com; not to place undue
reliance on forward-looking statements and forward-looking
information; be aware the Company does not assume any obligation to
update the forward-looking statements and forward-looking
information contained in this Annual Information Form other than as
required by applicable laws (including without limitation Section
5.8(2) of National Instrument 51-102 (Continuous Disclosure
Obligations).
Neither TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
CardioComm Solutions (TSXV:EKG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024